Nuovi Orientamenti Nel Trattamento Chemioterapico Del Carcinoma Gastrico

Abstract

Get full access to this article

View all access options for this article.

References

Parkin

D.M.

, Laara

, Muir

C.S.

: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int. J. Cancer, 41: 184–197, 1980.

Zanetti

, Crosignani

, Rosso

: Il cancro in Italia. Il Pensiero Scientifico Editore, Roma, 1997.

Kelsen

: Adjuvant and neoadjuvant therapy for gastric cancer. Semin. Oncol., 23: 379–389, 1996.

Rougier

, Lasser

, Ducreux

: Preoperative chemotherapy of locally advanced gastric cancer. Ann. Oncol., 5: 59–68, 1994.

Sussman

, Halvorsen

R.A.

, Illescas

F.F.

: Gastric adenocarcinoma: CT versus surgical staging. Radiology, 167, 335–340, 1988.

Cascinu

, Labianca

, Graziano

: Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Br. J. Cancer, 78: 390–393, 1998.

Wilke

, Preusser

, Fink

: New developments in the treatment of gastric carcinoma. Semin. Oncol., 17: 61–70, 1990.

Rosen

H.R.

, Scheithauer

, Jakesz

: Epirubicin, etoposide and cisplatin in the treatment of locally advanced nonresectable gastric carcinoma-results of a multicentric pilot study. Gl Cancer, 1: 49–53, 1995.

Plukker

, Muldor

N.H.

, Sleijfer

D.T.

: Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5fluorouracil. Br. J. Surg., 7: 1318–1326, 1991.

10.

Schuhmacher

C.H.

, Fink

, Boettcher

: Neoadjuvant chemotherapy for locally advanced gastric cancer: a phase II study with etoposide, adryamicin and cisplatin. Ann. Oncol., 5: 380, 1994.

11.

Melcher

A.A.

, Mori

, Maughan

T.S.

: Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer. Br. J. Cancer, 74: 1651–1654, 1996.

12.

Kelsen

, Atiq

O.T.

, Saltz

: FAMTX versus etoposide, doxorubicin and cisplatin: a random assignment trial in gastric cancer. J. Clin. Oncol., 10: 541–548, 1992.

13.

Cocconi

, Bella

, Zironi

: FAMTX versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research. J. Clin. Oncol., 12: 2687–2693, 1994.

14.

Webb

, Cunningham

, Scarffe

J.H.

: Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil doxorubicin and methotrexate in advanced esophago-gastric cancer. J. Clin. Oncol., 15: 261–267, 1997.

15.

Cascinu

, Graziano

, Del Ferro

: Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma. Cancer, 83: 1917–1922, 1998.

16.

Boku

, Chin

, Hosokawa

: Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cisplatinum. Clin. Cancer Res., 4: 1469–1474, 1998.

17.

Schipper

D.L.

, Wagener

D.J.T.

: Chemotherapy of gastric cancer. Anti-Cancer Drugs, 7: 137–149, 1996.

18.

Hermans

, Bonenkamp

J.J.

, Boon

M.C.

: Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J. Clin. Oncol., 11: 1441–1447, 1993.

19.

Floriani

, Belfiglio

, Cascinu

: Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomized trials. Tumori, 84(suppl. 1): 142, 1998.

20.

Pyrhonen

, Kultunen

, Nyandoto

: Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non resectable gastric cancer. Br. J. Cancer, 71: 587–591, 1995.

21.

Murad

A.M.

, Santiago

E.F.

, Petrolanu

: Modified therapy with 5fluorouracil, doxorubicin and methotrexate in advanced gastric cancer. Cancer, 72: 37–41, 1993.

22.

Glimelius

, Hoffmann

, Huglund

: Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann. Oncol., 5: 189–190, 1994.

23.

MacDonald

J.S.

, Schein

P.S.

, Wooley

P.V.

: 5-fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for advanced gastric cancer. Ann. Intern. Med., 93: 533–536, 1980.

24.

Wils

, Bleiberg

, Garbrecht

: An EORTC gastrointestinal evaluation of the combination of sequential methotrexate and 5-fluorouracil combined with adryamicin in advanced measurable gastric cancer. J. Clin. Oncol., 4: 1799–1803, 1986.

25.

Preusser

, Wilke

I.I.

, Achtermath

: Phase II study with the combination etoposide, doxorubicin and cisplatin in advanced measurable gastric cancer. J. Clin. Oncol., 7: 1310–1317, 1989.

26.

Wils

, Klein

H.O.

, Wagener

D.J.T.

: Sequential high dose methotrexate and 5-fluorouracil combined with doxorubicin: a step ahead in the treatment of advanced gastric cancer. J. Clin. Oncol., 9: 827–831, 1991.

27.

Cascinu

, Latini

, Fedeli

: The clinical impact of FEM regimen in advanced gastric cancer patients. Anticancer Res., 15: 2781–2784, 1995.

28.

Findlay

, Cunningham

, Norman

: A phase II study in advanced gastroesophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann. Oncol., 5: 609–616, 1994.

29.

Zaniboni

, Barni

, Labianca

: Epirubicin, cisplatin and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. Cancer, 76: 1694–1699, 1995.

30.

Cascinu

, Fedeli

, Luzi Fedeli

: Intensive weekly chemotherapy for advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leuocovorin and G-CSF. Int. J. Oncol., 3: 535–538, 1993.

31.

Cascinu

, Labianca

, Alessandroni

: Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer. J. Clin. Oncol., 15: 3313–3319, 1997.